Skip to content
Donate Now
  • Donate Now
  • The Foundation for Financial Journalism
  • The Foundation for Financial Journalism
  • About Us
  • Contact
  • Donors
  • The Foundation in the News
  • Topics
    • Environment
    • Financial Services
    • Health Care
    • Hedge Funds
    • Hospitality Industry
    • Insys Therapeutics
    • Investing
    • Marijuana Industry
    • multilevel marketing
    • Pharma
    • Philanthropy
    • Tech
    • Transportation
    • Wirecard
  • Documents
  • Support Us
  • Donate Now

The Foundation for Financial Journalism Investigative reporting for accountability and the truth

The Foundation for Financial Journalism (https://ffj-online.org/sirf-documents-2/)

  • About Us
  • Contact
  • Donors
  • The Foundation in the News
  • Topics
    • Environment
    • Financial Services
    • Health Care
    • Hedge Funds
    • Hospitality Industry
    • Insys Therapeutics
    • Investing
    • Marijuana Industry
    • multilevel marketing
    • Pharma
    • Philanthropy
    • Tech
    • Transportation
    • Wirecard
  • Documents
  • Support Us

Documents

View the IRS’ 2013 approval of the foundation’s tax-exempt status under Section 501(c)(3).

See the foundation’s Form 990-EZ for the following tax years:

2020

2019

2018

2017

2016

2015

2014

2013

2012

Support The Foundation for Financial Journalism

We depend on your support. A generous gift in any amount helps us continue to bring you this service.

Donate Now

Read more on:

  • Insys Therapeutics
     Corcept Therapeutics: The Company That Perfectly Explains the Health Care Crisis
  • Investing
     Fraser Perring: Chronicles of Deceit, Part I
  • multilevel marketing
     The Infernal Machine: From Powder to Dust
  • Marijuana Industry
     What’s in a Name? The Ongoing Saga of Medbox
  • Environment
     Who Owns Our Water?

Recent Articles

  • Danny Guy, Derrick Snowdy and the Strange Wars of Confused Men

    Derrick Snowdy is probably as close to a celebrity as Canada’s private investigator community has. Starting in 2010, Snowdy burst into view as a prime mover in the political controversy colloquially known as “the busty hookers scandal.” Snowdy proved to be a quick study at capturing an audience’s attention, ever ready to regale listeners with […]

  • For Jazz Pharmaceuticals, Failure Is the New Winning

    To U.S. oncologists who treat individuals with small cell lung cancer, lurbinectedin’s arrival was a big deal. The Food and Drug Administration permitted its sale in the United States under its accelerated approval program. Then the drug failed to meet the primary endpoint of its clinical trial’s Phase III.

  • Freedom Holding: After ‘Borat,’ the Silliest Kazakh Import of the Century

    Investors might be shocked to learn what lies behind the recent muscular share price growth of Freedom Holding Corp., a Las Vegas–incorporated bank and securities brokerage with its principal office in Almaty, Kazakhstan. Freedom Holding’s astronomical revenue growth has seemingly made it the fastest-growing financial services company on Earth.

  • Penumbra Inc.’s Catheter Fail: Broken Tips and Lost Lives

    Voluntary reports submitted to a Food and Drug Administration database, including entries from surgeons, paint a picture of a new Penumbra catheters whose safety problems the company may be forced to address in a substantive manner.

  • Illustration: Edel Rodriguez
    The U5 Loophole

    The U5 is one of the most important documents on Wall Street. And negotiations to discuss them can easily become a battleground where employers and employees fight over whether an upcoming exit will be classified as a resignation or a firing — and if problematic behavior is revealed.

  • Foundation for Financial Journalism
  • About Us
  • Contact
  • Donors
  • Support Us

Search This Site

Browse Archives

© Copyright 2021, the Foundation for Financial Journalism

The Foundation for Financial Journalism is a member of the Institute for Nonprofit News

Built with the Largo WordPress Theme from the Institute for Nonprofit News.

Back to top ↑